Compare LAD & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAD | IBRX |
|---|---|---|
| Founded | 1946 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 7.2B |
| IPO Year | 1996 | 2015 |
| Metric | LAD | IBRX |
|---|---|---|
| Price | $334.82 | $7.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $361.89 | $12.57 |
| AVG Volume (30 Days) | 275.7K | ★ 12.2M |
| Earning Date | 04-29-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | 9.01 | ★ 38.71 |
| EPS | ★ 4.28 | N/A |
| Revenue | ★ $11,821,400,000.00 | $113,288,000.00 |
| Revenue This Year | $4.06 | $88.59 |
| Revenue Next Year | $4.18 | $131.15 |
| P/E Ratio | $78.68 | ★ N/A |
| Revenue Growth | 17.20 | ★ 668.31 |
| 52 Week Low | $239.78 | $1.95 |
| 52 Week High | $360.56 | $12.43 |
| Indicator | LAD | IBRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.65 | 45.06 |
| Support Level | $321.18 | $6.69 |
| Resistance Level | $344.35 | $8.54 |
| Average True Range (ATR) | 10.94 | 0.57 |
| MACD | 3.23 | -0.15 |
| Stochastic Oscillator | 81.93 | 17.74 |
Lithia Motors is a retailer of new and used vehicles and related services. The company offers nearly 60 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2025 was $37.6 billion and we see over $50 billion possible in a few years. The US was 78.5% of 2025 revenue and the UK second at 18.4%, due to the 2024 Pendragon acquisition. In 2025, new vehicle sales were about 50% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.